Spots Global Cancer Trial Database for Pore Excision, Curettage, and Injection of Cymetra for Pilonidal Disease

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Pore Excision, Curettage, and Injection of Cymetra for Pilonidal Disease

Official Title: Pore Excision, Curettage, and Injection of a Tissue Scaffold as Treatment for Pilonidal Disease

Study ID: NCT00493493

Conditions

Pilonidal Sinus

Interventions

surgery (Pore Excision, Curettage, and Injection of Cymetra)

Study Description

Brief Summary: Chronic pilonidal disease is a common problem with no ideal treatment. This is a prospective study that will evaluate the results of surgical pore excision, curettage, and injection of a regenerative tissue matrix, Cymetra, on patients with chronic pilonidal disease.

Detailed Description: In addition, the study will evaluate the credibility and reproducibility of results within other surgeons trained to perform the procedure. Data collection will focus on post-operative wound failure, infection ratwes, analgesic requirements, time lost from work or school, wound care requirements, and 6 month recurrence rates. These outcomes will be compared to outcomes using conventional pilonidal surgical intervention using published data.